Inventor
SWEET RAYMOND
US38 patents
⚠️ This page may combine multiple inventors who share the name “SWEET RAYMOND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
23 patentsUS7993645B2Aug 9, 2011
Human anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC57 citations97
US9102737B2Aug 11, 2015
Human anti-CD27 antibodies, methods and uses
JANSSEN BIOTECH INC36 citations96
US10030070B2Jul 24, 2018
Human anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC11 citations92
US9783607B2Oct 10, 2017
Human anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC10 citations92
US9522957B2Dec 20, 2016
Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists
JANSSEN BIOTECH INC10 citations92
US9683046B2Jun 20, 2017
Nucleic acid molecules encoding anti-CD27 antibodies
JANSSEN BIOTECH INC7 citations83
US9481731B2Nov 1, 2016
Toll-like receptor 3 antagonists
JANSSEN BIOTECH INC9 citations83
US10576150B2Mar 3, 2020
Anti-IL-23 antibodies
JANSSEN BIOTECH INC1 citations73
US10272152B2Apr 30, 2019
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC1 citations73
US10301392B2May 28, 2019
Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies
JANSSEN BIOTECH INC3 citations72
US12065488B2Aug 20, 2024
Anti-IL-6 antibody
JANSSEN BIOTECH INC0 citations62
US11185584B2Nov 30, 2021
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations62
US11180549B2Nov 23, 2021
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
JANSSEN BIOTECH INC0 citations62
US9932404B2Apr 3, 2018
Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
JANSSEN BIOTECH INC1 citations62
US12129293B2Oct 29, 2024
Medical device for administering anti-IL-23 antibodies
JANSSEN BIOTECH INC0 citations61
US11732050B2Aug 22, 2023
Neutralizing human anti-CD27 antibodies
JANSSEN BIOTECH INC0 citations61
US10954297B2Mar 23, 2021
Methods of treatment using human anti-IL-23 antibodies
JANSSEN BIOTECH INC0 citations61
US12161716B2Dec 10, 2024
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations59
US9714287B2Jul 25, 2017
Anti-IL-23 antibody compositions
JANSSEN BIOTECH INC0 citations52
US10689453B2Jun 23, 2020
Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
JANSSEN BIOTECH INC0 citations51
US9505837B2Nov 29, 2016
Anti-IL-23 antibodies
JANSSEN BIOTECH INC0 citations51
US9127058B2Sep 8, 2015
Anti-IL-23 Antibodies
JANSSEN BIOTECH INC0 citations51
US9096667B2Aug 4, 2015
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations51
CUNNINGHAM MARK
5 patentsUS9255153B2Feb 9, 2016
Polynucleotides encoding Toll-Like Receptor 3 antagonists
CUNNINGHAM MARK10 citations91
US9238693B2Jan 19, 2016
Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies
CUNNINGHAM MARK3 citations82
US8540986B2Sep 24, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
US8460659B2Jun 11, 2013
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
CUNNINGHAM MARK2 citations61
US8409567B2Apr 2, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
BENSON JACQUELINE
3 patentsUS8221760B2Jul 17, 2012
Methods of treatment using human anti-IL-23 antibodies
BENSON JACQUELINE29 citations95
US8106177B2Jan 31, 2012
Nucleic acids encoding human anti-IL-23 antibodies
BENSON JACQUELINE34 citations95
US9353181B2May 31, 2016
Human anti-IL-23 antibodies, compositions, methods and uses
BENSON JACQUELINE22 citations92